glp 1 or mounjaro GLP-1 Weight Loss Treatments: Ozempic, Mounjaro, and Other Options| PMN What You Need to Know

FDA approval was based on the SOUL cardiovascular outcomes trial (CVOT) that demonstrated a 14% relative reduction in risk of MACE in patients treated with Rybelsus 14 mg orally once daily for approximately 5 years compared to those who received placebo

Edwin Davila, an osteopathic physician and member of NASMs Scientific Advisory Board

The Tirzepatide Weight Loss Program is a clinician-guided telehealth program built around compounded tirzepatide, a dual-action medication that works on two metabolic pathways (GIP and GLP-1) to reduce appetite, quiet food noise, and support blood sugar balance

Remember, weight loss with this treatment is generally gradual and steady, rather than rapid

N Engl J Med2010;362:774-7